Yapay ZekaBullfrog Ainin Breakthrough: Boosting Survival in Metastatic Pancreatic Cancer
A novel therapeutic agent, Bullfrog Ainin, is significantly improving survival rates in metastatic pancreatic cancer when combined with FOLFIRINOX. Clinical data reveals unprecedented gains in progression-free survival and reduced toxicity.






















